Maxcyte (MXCT) Asset Writedowns and Impairment (2023 - 2026)
Maxcyte (MXCT) reported Asset Writedowns and Impairment of $197000.0 for Q1 2026, up 203.08% year-over-year from $65000.0 in Q1 2025, and up 3183.33% quarter-over-quarter from $6000.0 in Q4 2025.
Maxcyte (MXCT) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends
Maxcyte (MXCT) has 4 years of Asset Writedowns and Impairment data on file, last reported at $197000.0 in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $197000.0, up 203.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $167000.0 (down 90.21% YoY), and the FY2025 annual result was $35000.0, down 98.02% from the prior year.
- Asset Writedowns and Impairment grew to $197000.0 in Q1 2026 per MXCT's latest filing, from $6000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $964000.0 in Q3 2024 and troughed at -$260000.0 in Q2 2024.
- A 4-year average of $176727.3 and a median of $65000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment surged 10811.11% in 2024, then sank 114.11% in 2025.
- A 4-year view of Asset Writedowns and Impairment shows it stood at -$50000.0 in 2023, then soared by 1974.0% to $937000.0 in 2024, then sank by 99.36% to $6000.0 in 2025, then soared by 3183.33% to $197000.0 in 2026.
- Business Quant data shows MXCT's Asset Writedowns and Impairment at $197000.0 in Q1 2026, $6000.0 in Q4 2025, and -$136000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Maxcyte | 120.23 Mn | 120.23 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 197,000.00 |
| Mar 31, 2026 | 197,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 937,000.00 |
| Dec 31, 2024 | 937,000.00 |
| Sep 30, 2024 | 964,000.00 |
| Sep 30, 2024 | 964,000.00 |
| Jun 30, 2024 | -260,000.00 |
| Jun 30, 2024 | -260,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Dec 31, 2023 | -50,000.00 |